Skip to main content
Navigate Up
Sign In

DETOUR I: 18-month results encouraging for percutaneous bypass system

“The DETOUR I trial showed excellent long-term safety in patients with advanced disease and extremely long, complex lesions, with venous health maintained at 18 months,” said Ehrin J. Armstrong, director of the VA Eastern Colorado Health Care System and associate professor of medicine at CU School of Medicine.